51716-62-2Relevant articles and documents
A synthetic approach to 5/5/6-polycyclic tetramate macrolactams of the discodermide type
Bodenschatz, Kevin,St?ckl, Julia,Winterer, Markus,Schobert, Rainer
, (2021/05/31)
A flexible synthetic route to the 16-membered tetramate-embedding macrocyclic scaffold present in various polycyclic tetramate macrolactams (PTMs) was developed which differs from the seminal synthesis of ikarugamycin by Boeckman Jr. in protecting groups and the order of connections. We also devised a short approach to various stereoisomers of the 5/5/6-tricarbocyclic motif found in discodermide and other PTMs, starting from the Weiss’ diketone.
Bicyclic derivative-containing inhibitor, preparation method and applications thereof
-
Paragraph 0260-0262; 0266-0268, (2020/04/17)
The invention relates to a bicyclic derivative-containing inhibitor, a preparation method and applications thereof, particularly to a compound represented by a general formula (I), and a preparation method thereof, a pharmaceutical composition containing the compound, and applications of the compound as an Acetyl-CoA Carboxylase (ACC) inhibitor in treatment of diseases or symptoms caused by fattyacid metabolic disorder.
Octahydropentalene compound, and preparation method and medical application thereof
-
Paragraph 0107-0112, (2019/12/25)
The invention relates to a novel octahydropentalene compound for regulating or inhibiting the activity of indoleamine 2,3-dioxygenase (IDO), and a preparation method and medicinal application of the octahydropentalene compound. Specifically, the invention relates to a compound as shown in a general formula (I) which is described in the specification and a pharmaceutically acceptable salt thereof,a pharmaceutical composition containing the compound or the pharmaceutically acceptable salt thereof, a method for treating and/or preventing related IDO-mediated diseases, especially tumors, by usingthe compound or the pharmaceutically acceptable salt thereof, and a preparation method for the compound or the pharmaceutically acceptable salt thereof. The invention also relates to the applicationof the compound or the pharmaceutically acceptable salt thereof or a pharmaceutical composition containing the compound or the pharmaceutically acceptable salt thereof in preparation of drugs for treating and/or preventing related IDO-mediated diseases, especially tumors. Each substituent of the general formula (I) is as defined in the specification.